Erratum to 'Safety, efficacy and outcome-related factors of perampanel over 12months in a real-world setting: The FYDATA study' [Epilepsy Res. 126 (2016) 201-210]

Autor:	Montserrat González-Cuevas, Ana Suller, Xiana Rodríguez-Osorio, V. Villanueva, J. Montoya, Manuel Toledo, Francisco Javier López-González, J. López-Trigo, Rosa Querol, Jose Serratosa, J.J. Baigesr, A. Castillo, Dulce Campos, J.L. Camacho, Juan José Poza, Javier Salas-Puig, Joaquín Ojeda, Beatriz González-Giráldez, J. Rodríguez-Uranga, R. Saiz-Diaz, Julieta Gertrudis Estrada Flores, Pau Giner, Mar Carreño, Mercedes Garcés, J. González-de la Aleja, J.B. Gómez, P. Esteve, Albert Molins, José Ángel Mauri
Rok vydání:	2016
Předmět:	0301 basic medicine Related factors medicine.medical_specialty business.industry Published Erratum MEDLINE Pharmacology medicine.disease Outcome (game theory) 03 medical and health sciences Epilepsy Perampanel chemistry.chemical_compound 030104 developmental biology 0302 clinical medicine Neurology chemistry medicine Neurology (clinical) Intensive care medicine business 030217 neurology & neurosurgery
Zdroj:	Epilepsy research. 129
ISSN:	1872-6844
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50ada3310fbd63cf351a3afd8529bdb1 https://pubmed.ncbi.nlm.nih.gov/27521586 Zobrazit plný text záznamu Full Text from ScienceDirect